ArticleFrontiers in oncology2020

Monitoring of Early Changes of Circulating Tumor DNA in the Plasma of Rectal Cancer Patients Receiving Neoadjuvant Concomitant Chemoradiotherapy: Evaluation for Prognosis and Prediction of Therapeutic Response.

Filip Pazdirek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.